0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immuno-Cell Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33O14203
Home | Market Reports | Health| Nursing
Global Immuno Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global Immuno-Cell Therapy Market Research Report 2025

Code: QYRE-Auto-33O14203
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Immuno-Cell Therapy Market

The global market for Immuno-Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
North American market for Immuno-Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Immuno-Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Immuno-Cell Therapy in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Immuno-Cell Therapy include MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences, Novartis, Osiris, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immuno-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Cell Therapy.
The Immuno-Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immuno-Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Immuno-Cell Therapy Market Report

Report Metric Details
Report Name Immuno-Cell Therapy Market
Segment by Type
  • Passive Immune (NK, LAK etc)
  • Active Immune
Segment by Application
  • Oncology
  • Cardiovascular Disease (CVD)
  • Orthopedic
  • Wound Healing
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences, Novartis, Osiris, Vericel Corporation, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech, Beroni Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Immuno-Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immuno-Cell Therapy Market report?

Ans: The main players in the Immuno-Cell Therapy Market are MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences, Novartis, Osiris, Vericel Corporation, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech, Beroni Group

What are the Application segmentation covered in the Immuno-Cell Therapy Market report?

Ans: The Applications covered in the Immuno-Cell Therapy Market report are Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Others

What are the Type segmentation covered in the Immuno-Cell Therapy Market report?

Ans: The Types covered in the Immuno-Cell Therapy Market report are Passive Immune (NK, LAK etc), Active Immune

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Passive Immune (NK, LAK etc)
1.2.3 Active Immune
1.3 Market by Application
1.3.1 Global Immuno-Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Cell Therapy Market Perspective (2020-2031)
2.2 Global Immuno-Cell Therapy Growth Trends by Region
2.2.1 Global Immuno-Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immuno-Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Immuno-Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Immuno-Cell Therapy Market Dynamics
2.3.1 Immuno-Cell Therapy Industry Trends
2.3.2 Immuno-Cell Therapy Market Drivers
2.3.3 Immuno-Cell Therapy Market Challenges
2.3.4 Immuno-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Cell Therapy Players by Revenue
3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immuno-Cell Therapy Revenue
3.4 Global Immuno-Cell Therapy Market Concentration Ratio
3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2024
3.5 Global Key Players of Immuno-Cell Therapy Head office and Area Served
3.6 Global Key Players of Immuno-Cell Therapy, Product and Application
3.7 Global Key Players of Immuno-Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Cell Therapy Breakdown Data by Type
4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Immuno-Cell Therapy Breakdown Data by Application
5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immuno-Cell Therapy Market Size (2020-2031)
6.2 North America Immuno-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immuno-Cell Therapy Market Size by Country (2020-2025)
6.4 North America Immuno-Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-Cell Therapy Market Size (2020-2031)
7.2 Europe Immuno-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immuno-Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Immuno-Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Immuno-Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immuno-Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Immuno-Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-Cell Therapy Market Size (2020-2031)
9.2 Latin America Immuno-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immuno-Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Immuno-Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Immuno-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immuno-Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Immuno-Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Details
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2020-2025)
11.1.5 MEDINET Co Recent Development
11.2 Erytech
11.2.1 Erytech Company Details
11.2.2 Erytech Business Overview
11.2.3 Erytech Immuno-Cell Therapy Introduction
11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2020-2025)
11.2.5 Erytech Recent Development
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Details
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2020-2025)
11.3.5 Seta Clinic Group Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Immuno-Cell Therapy Introduction
11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2020-2025)
11.4.5 Takeda Recent Development
11.5 SBI Holdings
11.5.1 SBI Holdings Company Details
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2020-2025)
11.5.5 SBI Holdings Recent Development
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Details
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2020-2025)
11.6.5 Oxford BioTherapeutics Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2020-2025)
11.7.5 Fate Therapeutics Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2020-2025)
11.8.5 Gilead Sciences Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Cell Therapy Introduction
11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Immuno-Cell Therapy Introduction
11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2020-2025)
11.10.5 Osiris Recent Development
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Details
11.11.2 Vericel Corporation Business Overview
11.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
11.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2020-2025)
11.11.5 Vericel Corporation Recent Development
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Details
11.12.2 Fujifilm Cellular Dynamics Business Overview
11.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
11.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2020-2025)
11.12.5 Fujifilm Cellular Dynamics Recent Development
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Details
11.13.2 JCR Pharmaceuticals Business Overview
11.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
11.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2020-2025)
11.13.5 JCR Pharmaceuticals Recent Development
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Details
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
11.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2020-2025)
11.14.5 Beike Biotechnology Recent Development
11.15 Golden Meditech
11.15.1 Golden Meditech Company Details
11.15.2 Golden Meditech Business Overview
11.15.3 Golden Meditech Immuno-Cell Therapy Introduction
11.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2020-2025)
11.15.5 Golden Meditech Recent Development
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Details
11.16.2 Guanhao Biotech Business Overview
11.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
11.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2020-2025)
11.16.5 Guanhao Biotech Recent Development
11.17 Beroni Group
11.17.1 Beroni Group Company Details
11.17.2 Beroni Group Business Overview
11.17.3 Beroni Group Immuno-Cell Therapy Introduction
11.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2020-2025)
11.17.5 Beroni Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Immuno-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Passive Immune (NK, LAK etc)
 Table 3. Key Players of Active Immune
 Table 4. Global Immuno-Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Immuno-Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Immuno-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Immuno-Cell Therapy Market Share by Region (2020-2025)
 Table 8. Global Immuno-Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Immuno-Cell Therapy Market Share by Region (2026-2031)
 Table 10. Immuno-Cell Therapy Market Trends
 Table 11. Immuno-Cell Therapy Market Drivers
 Table 12. Immuno-Cell Therapy Market Challenges
 Table 13. Immuno-Cell Therapy Market Restraints
 Table 14. Global Immuno-Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Immuno-Cell Therapy Market Share by Players (2020-2025)
 Table 16. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2024)
 Table 17. Ranking of Global Top Immuno-Cell Therapy Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Immuno-Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Immuno-Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Immuno-Cell Therapy, Product and Application
 Table 21. Global Key Players of Immuno-Cell Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Immuno-Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Immuno-Cell Therapy Revenue Market Share by Type (2020-2025)
 Table 25. Global Immuno-Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Immuno-Cell Therapy Revenue Market Share by Type (2026-2031)
 Table 27. Global Immuno-Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Immuno-Cell Therapy Revenue Market Share by Application (2020-2025)
 Table 29. Global Immuno-Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Immuno-Cell Therapy Revenue Market Share by Application (2026-2031)
 Table 31. North America Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Immuno-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Immuno-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Immuno-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Immuno-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Immuno-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Immuno-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Immuno-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. MEDINET Co Company Details
 Table 47. MEDINET Co Business Overview
 Table 48. MEDINET Co Immuno-Cell Therapy Product
 Table 49. MEDINET Co Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 50. MEDINET Co Recent Development
 Table 51. Erytech Company Details
 Table 52. Erytech Business Overview
 Table 53. Erytech Immuno-Cell Therapy Product
 Table 54. Erytech Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 55. Erytech Recent Development
 Table 56. Seta Clinic Group Company Details
 Table 57. Seta Clinic Group Business Overview
 Table 58. Seta Clinic Group Immuno-Cell Therapy Product
 Table 59. Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 60. Seta Clinic Group Recent Development
 Table 61. Takeda Company Details
 Table 62. Takeda Business Overview
 Table 63. Takeda Immuno-Cell Therapy Product
 Table 64. Takeda Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 65. Takeda Recent Development
 Table 66. SBI Holdings Company Details
 Table 67. SBI Holdings Business Overview
 Table 68. SBI Holdings Immuno-Cell Therapy Product
 Table 69. SBI Holdings Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 70. SBI Holdings Recent Development
 Table 71. Oxford BioTherapeutics Company Details
 Table 72. Oxford BioTherapeutics Business Overview
 Table 73. Oxford BioTherapeutics Immuno-Cell Therapy Product
 Table 74. Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 75. Oxford BioTherapeutics Recent Development
 Table 76. Fate Therapeutics Company Details
 Table 77. Fate Therapeutics Business Overview
 Table 78. Fate Therapeutics Immuno-Cell Therapy Product
 Table 79. Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 80. Fate Therapeutics Recent Development
 Table 81. Gilead Sciences Company Details
 Table 82. Gilead Sciences Business Overview
 Table 83. Gilead Sciences Immuno-Cell Therapy Product
 Table 84. Gilead Sciences Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 85. Gilead Sciences Recent Development
 Table 86. Novartis Company Details
 Table 87. Novartis Business Overview
 Table 88. Novartis Immuno-Cell Therapy Product
 Table 89. Novartis Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 90. Novartis Recent Development
 Table 91. Osiris Company Details
 Table 92. Osiris Business Overview
 Table 93. Osiris Immuno-Cell Therapy Product
 Table 94. Osiris Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 95. Osiris Recent Development
 Table 96. Vericel Corporation Company Details
 Table 97. Vericel Corporation Business Overview
 Table 98. Vericel Corporation Immuno-Cell Therapy Product
 Table 99. Vericel Corporation Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 100. Vericel Corporation Recent Development
 Table 101. Fujifilm Cellular Dynamics Company Details
 Table 102. Fujifilm Cellular Dynamics Business Overview
 Table 103. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product
 Table 104. Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 105. Fujifilm Cellular Dynamics Recent Development
 Table 106. JCR Pharmaceuticals Company Details
 Table 107. JCR Pharmaceuticals Business Overview
 Table 108. JCR Pharmaceuticals Immuno-Cell Therapy Product
 Table 109. JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 110. JCR Pharmaceuticals Recent Development
 Table 111. Beike Biotechnology Company Details
 Table 112. Beike Biotechnology Business Overview
 Table 113. Beike Biotechnology Immuno-Cell Therapy Product
 Table 114. Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 115. Beike Biotechnology Recent Development
 Table 116. Golden Meditech Company Details
 Table 117. Golden Meditech Business Overview
 Table 118. Golden Meditech Immuno-Cell Therapy Product
 Table 119. Golden Meditech Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 120. Golden Meditech Recent Development
 Table 121. Guanhao Biotech Company Details
 Table 122. Guanhao Biotech Business Overview
 Table 123. Guanhao Biotech Immuno-Cell Therapy Product
 Table 124. Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 125. Guanhao Biotech Recent Development
 Table 126. Beroni Group Company Details
 Table 127. Beroni Group Business Overview
 Table 128. Beroni Group Immuno-Cell Therapy Product
 Table 129. Beroni Group Revenue in Immuno-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 130. Beroni Group Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Immuno-Cell Therapy Picture
 Figure 2. Global Immuno-Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Immuno-Cell Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Passive Immune (NK, LAK etc) Features
 Figure 5. Active Immune Features
 Figure 6. Global Immuno-Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Immuno-Cell Therapy Market Share by Application: 2024 VS 2031
 Figure 8. Oncology Case Studies
 Figure 9. Cardiovascular Disease (CVD) Case Studies
 Figure 10. Orthopedic Case Studies
 Figure 11. Wound Healing Case Studies
 Figure 12. Others Case Studies
 Figure 13. Immuno-Cell Therapy Report Years Considered
 Figure 14. Global Immuno-Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Immuno-Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Immuno-Cell Therapy Market Share by Region: 2024 VS 2031
 Figure 17. Global Immuno-Cell Therapy Market Share by Players in 2024
 Figure 18. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Immuno-Cell Therapy Revenue in 2024
 Figure 20. North America Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Immuno-Cell Therapy Market Share by Country (2020-2031)
 Figure 22. United States Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Immuno-Cell Therapy Market Share by Country (2020-2031)
 Figure 26. Germany Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Immuno-Cell Therapy Market Share by Region (2020-2031)
 Figure 34. China Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Immuno-Cell Therapy Market Share by Country (2020-2031)
 Figure 42. Mexico Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Immuno-Cell Therapy Market Share by Country (2020-2031)
 Figure 46. Turkey Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Immuno-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. MEDINET Co Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 50. Erytech Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 51. Seta Clinic Group Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 52. Takeda Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 53. SBI Holdings Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 54. Oxford BioTherapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 55. Fate Therapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 56. Gilead Sciences Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 57. Novartis Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 58. Osiris Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 59. Vericel Corporation Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 60. Fujifilm Cellular Dynamics Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 61. JCR Pharmaceuticals Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 62. Beike Biotechnology Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 63. Golden Meditech Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 64. Guanhao Biotech Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 65. Beroni Group Revenue Growth Rate in Immuno-Cell Therapy Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart